Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07181265

Drug-Drug Interaction of JMKX003142 With Amiodarone and Febuxostat in Healthy Subjects

A Single-center, Non-randomized, Open-label, Self-controlled Phase I Drug-drug Interaction Clinical Study to Evaluate the Pharmacokinetics of JMKX003142 With Amiodarone, and Febuxostat in Chinese Healthy Subjects

Status
Not Yet Recruiting
Phase
Phase 1
Study type
Interventional
Enrollment
48 (estimated)
Sponsor
Jemincare · Industry
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

This is a open-label, non-randomized, multiple oral dosings, three-period, drug-drug interaction study of JMKX003142 tablet, Amiodarone Hydrochloride Tablets and Febuxostat Tablets in Chinese healthy adult subjects

Conditions

Interventions

TypeNameDescription
DRUGAmiodarone Hydrochloride TabletsCohort 1: The intervention is for study of drug drug interaction of JMKX003142 when administered with Amiodarone
DRUGFebuxostat TabletsCohort 2: The intervention is for study of drug drug interaction of JMKX003142 when administered with Febuxostat Tablets

Timeline

Start date
2025-10-30
Primary completion
2026-04-30
Completion
2026-06-30
First posted
2025-09-18
Last updated
2025-09-18

Source: ClinicalTrials.gov record NCT07181265. Inclusion in this directory is not an endorsement.

Drug-Drug Interaction of JMKX003142 With Amiodarone and Febuxostat in Healthy Subjects (NCT07181265) · Clinical Trials Directory